Trial intelligence / Profile preview

Prophylactic tranexamic acid capsules for control of epistaxis

IRCT20180425039418N7Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in epistaxis, sponsored by Zahedan University of Medical Sciences. Started Dec 2018; status: completed.

02

Drugs

tranexamic acid
03

Conditions

epistaxis

Beyond the preview

Go deeper on IRCT20180425039418N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180425039418N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call